321 related articles for article (PubMed ID: 38651407)
1. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes.
Bass LE; Bonami RH
Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38651407
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
3. B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes.
Felton JL; Conway H; Bonami RH
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33418839
[TBL] [Abstract][Full Text] [Related]
4. B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes.
Packard TA; Smith MJ; Conrad FJ; Johnson SA; Getahun A; Lindsay RS; Hinman RM; Friedman RS; Thomas JW; Cambier JC
J Clin Med; 2016 Nov; 5(11):. PubMed ID: 27834793
[TBL] [Abstract][Full Text] [Related]
5. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
Hampe CS
Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
[TBL] [Abstract][Full Text] [Related]
6. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice.
Banach M; Harley ITW; Getahun A; Cambier JC
Front Immunol; 2022; 13():961209. PubMed ID: 36275764
[TBL] [Abstract][Full Text] [Related]
8. Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.
Mauvais FX; Diana J; van Endert P
F1000Res; 2016; 5():. PubMed ID: 27158463
[TBL] [Abstract][Full Text] [Related]
9. Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.
Itoh A; Ridgway WM
Immunotargets Ther; 2017; 6():31-38. PubMed ID: 28580341
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis.
Li Y; Sun F; Yue TT; Wang FX; Yang CL; Luo JH; Rong SJ; Xiong F; Zhang S; Wang CY
Front Immunol; 2021; 12():690783. PubMed ID: 34335595
[TBL] [Abstract][Full Text] [Related]
11. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.
Alleva DG; Delpero AR; Sathiyaseelan T; Murikipudi S; Lancaster TM; Atkinson MA; Wasserfall CH; Yu L; Ragupathy R; Bonami RH; Zion TC
Front Immunol; 2024; 15():1367514. PubMed ID: 38515750
[TBL] [Abstract][Full Text] [Related]
12. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen.
Ahmed R; Omidian Z; Giwa A; Cornwell B; Majety N; Bell DR; Lee S; Zhang H; Michels A; Desiderio S; Sadegh-Nasseri S; Rabb H; Gritsch S; Suva ML; Cahan P; Zhou R; Jie C; Donner T; Hamad ARA
Cell; 2019 May; 177(6):1583-1599.e16. PubMed ID: 31150624
[TBL] [Abstract][Full Text] [Related]
13. Cell-Surface Autoantibody Targets Zinc Transporter-8 (ZnT8) for In Vivo β-Cell Imaging and Islet-Specific Therapies.
Guo Z; Kasinathan D; Merriman C; Nakayama M; Li H; Li H; Xu C; Wong GW; Yu L; Golson ML; Fu D
Diabetes; 2023 Feb; 72(2):184-195. PubMed ID: 36448936
[TBL] [Abstract][Full Text] [Related]
14. Role of B lymphocytes in the pathogenesis of type 1 diabetes.
Hinman RM; Cambier JC
Curr Diab Rep; 2014; 14(11):543. PubMed ID: 25189436
[TBL] [Abstract][Full Text] [Related]
15. B cells and type 1 diabetes ...in mice and men.
Hinman RM; Smith MJ; Cambier JC
Immunol Lett; 2014 Aug; 160(2):128-32. PubMed ID: 24472603
[TBL] [Abstract][Full Text] [Related]
16. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
Su M; Lin Y; He Z; Lai L
Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
[TBL] [Abstract][Full Text] [Related]
18. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
20. Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes.
Ratiu JJ; Racine JJ; Hasham MG; Wang Q; Branca JA; Chapman HD; Zhu J; Donghia N; Philip V; Schott WH; Wasserfall C; Atkinson MA; Mills KD; Leeth CM; Serreze DV
J Immunol; 2017 Jun; 198(11):4255-4267. PubMed ID: 28461573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
